Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in Indigenous Australians.
Longstreet DA et al.
Rural Remote Health. 2007;7:843.
These researchers discuss the evidence in support of a clinical correlation between diabetes and low dietary magnesium intake in the Indigenous population of Queensland.
Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
Song Y et al.
Diabet Med. 2006;23:1050-6.
This review of clinical evidence on the effect of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes mellitus concludes that such treatment for 4-16 weeks may be effective in reducing plasma fasting glucose levels and raising HDL cholesterol in this patient population.
Serum magnesium: an early predictor of course and complications of diabetes mellitus.
Sharma A et al.
J Indian Med Assoc. 2007;105:16, 18, 20.
An assessment of the relationship between serum magnesium in 50 type 1 and type 2 diabetic patients with or without complications and in 40 normal healthy subjects found significantly lower serum magnesium levels in the diabetic population compared to controls, and significantly lower serum magnesium in diabetes with complications versus without complications. In addition, poor glycaemic control was significantly associated with hypomagnesaemia.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment